Total Payments
$285,112
2024 Payments
$53,767
Companies
13
Transactions
463
Medicare Patients
222
Medicare Billing
$25,473
Payment Breakdown by Category
Other$227,533 (79.8%)
Travel$45,221 (15.9%)
Food & Beverage$8,560 (3.0%)
Consulting$3,751 (1.3%)
Education$46.91 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $227,533 | 110 | 79.8% |
| Travel and Lodging | $45,221 | 137 | 15.9% |
| Food and Beverage | $8,560 | 209 | 3.0% |
| Consulting Fee | $3,751 | 6 | 1.3% |
| Education | $46.91 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $143,349 | 242 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $136,787 | 187 | $0 (2024) |
| Indivior Inc. | $4,395 | 9 | $0 (2019) |
| Lundbeck LLC | $127.14 | 6 | $0 (2024) |
| Alkermes, Inc. | $101.82 | 5 | $0 (2023) |
| ABBVIE INC. | $88.76 | 4 | $0 (2024) |
| ITI, Inc. | $74.25 | 3 | $0 (2021) |
| Coloplast Corp | $68.87 | 1 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $45.11 | 2 | $0 (2021) |
| Allergan, Inc. | $24.60 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53,767 | 83 | Janssen Pharmaceuticals, Inc ($39,522) |
| 2023 | $50,307 | 73 | Janssen Pharmaceuticals, Inc ($38,251) |
| 2022 | $44,354 | 63 | Janssen Pharmaceuticals, Inc ($32,651) |
| 2021 | $16,358 | 28 | Janssen Pharmaceuticals, Inc ($12,843) |
| 2020 | $12,889 | 33 | Janssen Pharmaceuticals, Inc ($8,112) |
| 2019 | $48,580 | 95 | Otsuka America Pharmaceutical, Inc. ($32,275) |
| 2018 | $32,796 | 46 | Otsuka America Pharmaceutical, Inc. ($32,727) |
| 2017 | $26,062 | 42 | Otsuka America Pharmaceutical, Inc. ($25,925) |
All Payment Transactions
463 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,530.00 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $40.20 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | Cash or cash equivalent | $22.24 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $3.80 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,120.00 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,724.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $104.39 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | In-kind items and services | $1,336.12 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $67.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $59.96 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | Cash or cash equivalent | $22.24 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | Cash or cash equivalent | $7.08 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | Cash or cash equivalent | $6.04 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $157.60 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,640.00 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $1,372.00 | General |
| Category: Neuroscience | ||||||
| 10/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $139.14 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $50.92 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | Cash or cash equivalent | $45.39 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | Cash or cash equivalent | $26.95 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 50 | 104 | $10,636 | $7,195 |
| 2022 | 3 | 57 | 141 | $12,343 | $7,794 |
| 2021 | 3 | 61 | 144 | $9,132 | $5,478 |
| 2020 | 3 | 54 | 117 | $7,393 | $5,005 |
Total Patients
222
Total Services
506
Medicare Billing
$25,473
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 65 | $5,743 | $4,105 | 71.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 39 | $4,892 | $3,090 | 63.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 87 | $6,769 | $3,788 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 33 | $4,018 | $3,157 | 78.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 21 | $1,557 | $849.40 | 54.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 23 | 65 | $4,785 | $2,719 | 56.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 46 | $3,191 | $2,302 | 72.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 14 | 33 | $1,155 | $457.34 | 39.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 20 | 54 | $3,377 | $2,447 | 72.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 50 | $3,469 | $2,153 | 62.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 13 | $547.15 | $405.52 | 74.1% |
About Dr. Robert Davis, M.D
Dr. Robert Davis, M.D is a Psychiatry healthcare provider based in Greensburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912970559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Davis, M.D has received a total of $285,112 in payments from pharmaceutical and medical device companies, with $53,767 received in 2024. These payments were reported across 463 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($227,533).
As a Medicare-enrolled provider, Davis has provided services to 222 Medicare beneficiaries, totaling 506 services with total Medicare billing of $25,473. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Greensburg, PA
- Active Since 02/13/2006
- Last Updated 05/19/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1912970559
Products in Payments
- INVEGA SUSTENNA (Drug) $127,699
- ABILIFY MAINTENA (Drug) $98,354
- REXULTI (Drug) $27,966
- SPRAVATO (Drug) $15,023
- ABILIFY ASIMTUFII (Drug) $10,594
- PERSERIS (Drug) $4,395
- INVEGA TRINZA (Drug) $392.41
- INVEGA (Drug) $233.95
- VRAYLAR (Drug) $113.36
- CAPLYTA (Drug) $74.25
- FEMALE INCONTINENCE (Device) $68.87
- LYBALVI (Drug) $54.25
- ARISTADA (Drug) $47.57
- INGREZZA (Drug) $45.11
- VYXEOS (Drug) $19.67
- Trulance (Drug) $16.61
- Fanapt (Drug) $15.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Greensburg
Dr. Leyla Somen, Md, MD
Psychiatry — Payments: $9,252
Psychiatry $9,252
Saghir Ahmad, Md, MD
Psychiatry — Payments: $1,345
Psychiatry $1,345
Gowri Arulanantham, Md, MD
Psychiatry — Payments: $1,022
Psychiatry $1,022
Randall Orr, Md, MD
Psychiatry — Payments: $560.92
Psychiatry $560.92
Alan Reis, M.d, M.D
Psychiatry — Payments: $463.46
Psychiatry $463.46
Hai Wei Wang, Md, MD
Psychiatry — Payments: $274.58
Psychiatry $274.58